Bojun Chen
Kunming, 650500, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Natural Products as GPCR-Targeting Antidepressant Candidates: Advances and Opportunities.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 25, 2026
Chronic Paraventricular OX1R Overexpression Induces Oxidative Stress and Hypertension in Rats.
Journal: bioRxiv : the preprint server for biology
Published: February 23, 2026
Neuroimaging and molecular mechanism of action of Cang-ai volatile oil in the treatment of vascular cognitive impairment.
Journal: Frontiers in neuroscience
Published: August 19, 2025
Rhynchophylline Alleviates Hyperactivity and Cognitive Flexibility Impairment Associated With Inhibition of Inflammatory Responses in Mice That Partly Lack the Dopamine Transporter Protein.
Journal: Brain and behavior
Published: January 27, 2024
Cang-ai volatile oil alleviates nasal inflammation via Th1/Th2 cell imbalance regulation in a rat model of ovalbumin-induced allergic rhinitis.
Journal: Frontiers in pharmacology
Published: November 02, 2023
CAVO Inhibits Airway Inflammation and ILC2s in OVA-Induced Murine Asthma Mice.
Journal: BioMed research international
Published: September 30, 2022
Inhalation Aromatherapy via Brain-Targeted Nasal Delivery: Natural Volatiles or Essential Oils on Mood Disorders.
Journal: Frontiers in pharmacology
Published: February 04, 2022
Using 7.0 T cardiac magnetic resonance to investigate the effect of estradiol on biventricular structure and function of ovariectomized rats exposed to chronic hypobaric hypoxia at high altitude.
Journal: Archives of biochemistry and biophysics
Published: December 27, 2021
Cang-ai volatile oil improves depressive-like behaviors and regulates DA and 5-HT metabolism in the brains of CUMS-induced rats.
Journal: Journal of ethnopharmacology
Published: November 29, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026